| Reporting Organization: | UNICEF |
|---|---|
| Total Budget ($CAD): | $ 85,000,000 |
| Timeframe: | December 20, 2022 - March 31, 2025 |
| Status: | Unspecified |
| Contact Information: | Unspecified |
Unspecified
| Chad - $ 3,400,000.00 (4.00%) | |
| Bolivia - $ 3,400,000.00 (4.00%) | |
| Burkina Faso - $ 3,400,000.00 (4.00%) | |
| Burundi - $ 3,400,000.00 (4.00%) | |
| El Salvador - $ 3,400,000.00 (4.00%) | |
| Congo (the) - $ 3,400,000.00 (4.00%) | |
| Egypt - $ 3,400,000.00 (4.00%) | |
| Honduras - $ 3,400,000.00 (4.00%) | |
| Indonesia - $ 3,400,000.00 (4.00%) | |
| Mongolia - $ 3,400,000.00 (4.00%) | |
| Morocco - $ 3,400,000.00 (4.00%) | |
| Myanmar - $ 3,400,000.00 (4.00%) | |
| Somalia - $ 3,400,000.00 (4.00%) | |
| South Sudan - $ 3,400,000.00 (4.00%) | |
| Sri Lanka - $ 3,400,000.00 (4.00%) | |
| Sudan (the) - $ 3,400,000.00 (4.00%) | |
| Syrian Arab Republic - $ 3,400,000.00 (4.00%) | |
| Ukraine - $ 3,400,000.00 (4.00%) | |
| Philippines (the) - $ 3,400,000.00 (4.00%) | |
| Yemen - $ 3,400,000.00 (4.00%) | |
| Countries, unspecified - $ 3,400,000.00 (4.00%) | |
| Eswatini - $ 3,400,000.00 (4.00%) | |
| Palestine - $ 3,400,000.00 (4.00%) | |
| Kyrgyz Republic - $ 3,400,000.00 (4.00%) | |
| Sub-Saharan Africa - $ 3,400,000.00 (4.00%) | |
| Infectious & Communicable Diseases (100.00 %) | |
This project aims to strengthen COVID-19 response and recovery in approximately 25 of the COVAX Advance Market Commitment (AMC) 92 economies. It would reduce COVID-19 related mortality and morbidity, particularly amongst vulnerable and priority-use populations. It does so through increased support for the delivering and distributing COVID-19 vaccines. Project activities include: (1) supporting countries to plan and coordinate COVID-19 vaccine programs alongside routine immunization; (2) providing technical assistance for COVID-19 vaccine administration and storage; (3) procuring cold chain equipment and personal protective equipment; (4) strengthening data collection systems (5) providing bundled services to deliver vaccines, including in humanitarian contexts and (6) supporting health interventions that strengthen immunization and health systems.
| Gender and age: | Unspecified |
|---|---|
| Total Direct Population: | Unspecified |
Unspecified
Return to topThe expected outcomes of this project include: (1) increase equitable distribution and delivery of COVID-19 vaccines and strengthened gender-sensitive routine immunization in the AMC 92; (2) strengthen health systems to engage vulnerable and priority populations with gender-equitable COVID-19 vaccination and prevention communications and outreach in AMC 92 countries; and (3) increase country capacity and means to implement COVID-19 vaccination programs, including with the support needed to transition vaccination programs into routine immunization programs, as possible.
